According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is -$8.65. In 2022 the company made an earnings per share (EPS) of -$7.79 a decrease over its 2021 EPS that were of -$7.43.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$8.65 | 11.04% |
2022 | -$7.79 | 4.85% |
2021 | -$7.43 | 11.39% |
2020 | -$6.67 | 49.22% |
2019 | -$4.47 | 66.17% |
2018 | -$2.69 | 29.33% |
2017 | -$2.08 | -50.12% |
2016 | -$4.17 | -17.59% |
2015 | -$5.06 | 57.63% |
2014 | -$3.21 | 14.57% |
2013 | -$2.80 | 201.61% |
2012 | -$0.93 |